We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Iris Diagnostics to Supply Microscopy Technology to LabCorp

By Labmedica staff writers
Posted on 05 Oct 2006
Iris Diagnostics (Chatsworth, CA, USA), a division of Iris International, has entered into a five-year agreement to supply and service automated urine microscopy technology for Laboratory Corporation of America (LabCorp, Burlington, NC, USA). More...


Under the agreement, LabCorp has ordered 26 iQ200 Sprint urine microscopy analyzers from Iris Diagnostics, which will provide training, installation, service, and related reagents and consumables.

"After a comprehensive evaluation process, LabCorp chose our flagship iQ200 Sprint platform, with a throughput of 101 tests per hour and enhanced software that includes digital imaging and auto-particle recognition (APR), which classifies urine particles into 12 categories and quantitatively reports results,” said Dino Alfano, division president, Iris Diagnostics. "Its walk-away convenience in a bench-top system significantly reduces processing time and labor, adding significant value while increasing productivity. We look forward to partnering with LabCorp on this important urinalysis initiative and providing our innovative solution.”

Iris International supplies automated urinalysis technology to major medical institutions throughout the world. The Iris Molecular Diagnostics (IMD) subsidiary develops innovative ultra-sensitive diagnostics and sample-processing products with applications in the urinalysis, oncology, and infectious disease markets.

LabCorp is a large clinical reference laboratory, which operates a nationwide network of 36 primary testing locations and more than 1,300 patient service centers.



Related Links:
Iris Diagnostics
Laboratory Corporation of America

Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
ESR Analyzer
TEST1 2.0
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.